Biomedical Engineering Reference
In-Depth Information
lung fibrosis and subchronic tissue damage in mice,” Arch. Toxicol., 85,
pp. 1121-1131.
154. Aillon, K.L., Xie, Y., El-Gendy, N., Berkland, C.J., Forrest, M.L., 2009, “Effects
of nanomaterial physicochemical properties on in vivo toxicity,” Adv. Drug
Deliv. Rev., 61, pp. 457-466.
155. Nasibulin, A.G., Pikhitsa, P.V., Jiang, H., Brown, D.P., Krasheninnikov, A.V.,
et al., 2007, “A novel hybrid carbon material” Nat. Nanotechnol., 2, pp. 156-
161.
156. Yamakoshi, Y., Umezawa, N., Ryu, A., Arakane, K., Miyata, N., et al.,
2003, “Active oxygen species generated from photoexcited fullerene (C60)
as potential medicines: O2-*versus 1O2,” J. Am. Chem. Soc., 125, pp.
12803-12809.
157. Iwamoto, Y., and Yamakoshi, Y., 2006, “A highly water-soluble C60-NVP
copolymer: a potential material for photodynamic therapy,” Chem. Commun.,
46, pp. 4805-4807.
158. Liu, J., Ohta, S., Sonoda, A., Yamada, M., Yamamoto, M., et al., 2007,
“Preparation of PEG-conjugated fullerene containing Gd3+ ions for photo-
dynamic therapy,” J. Control Release, 117, pp. 104-110.
159. Zakharian, T.Y., Seryshev, A., Sitharaman, B., Gilbert, B.E., Knight, V., Wilson,
L.J., 2005,“A fullerene-paclitaxel chemotherapeutic: synthesis, characterization,
and study of biological activity in tissue culture,” J. Am. Chem. Soc., 127, pp.
12508-12509.
160. Abes, S., Ivanova, G.D., Abes, R., Arzumanov, A.A., Williams, D., et al., 2009,
“Peptide-based delivery of steric-block PNA oligonucleotides,” Methods Mol.
Biol., 480, pp. 85-99.
161. Chanda, N., Kattamuri, V., Shukla, V., Zambre, A., Katti, K., et al., 2010,
“Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer
receptor specificity,” Proc. Natl. Acad. Sci. U.S.A., 107, pp. 8760-8765.
162. Chen, X., Wang, X., Wang, Y., Yang, L., Hu, J., et al., 2010, “Improved tumor-
targeting drug delivery and therapeutic efficacy by cationic liposome modified
with truncated bFGF peptide,” J. Control. Release, 145, pp. 17-25.
163. Desai, A., Vyas, T., Amiji, M., 2008, “Cytotoxicity and apoptosis enhancement
in brain tumor cells upon coadministration of paclitaxel and ceramide in
nanoemulsion formulations,” J. Pharm. Sci., 97, pp. 2745-2756.
164. Pan, H., Soman, N.R., Schlesinger, P.H., Lanza, G.M., Wickline, S.A., 2009,
“Cytolitic peptides nanoparticles ('NanoBees') for cancer therapy,” Wires
Nanomed. Nanobiotechnol., 3, pp. 318-327.
165. Choi, J., Burns, A.A., Williams, R.M., Zhou, Z., Flesken-Nikitin, A., et al.,
2007, “Core-shell silica nanoparticles as fluorescent labels for nanomedicine,”
J. Biomed. Opt., 12, 064007.
166. He, X.X., Duan, J.H., Wang, K.M., Tan, W.H., Lin, X., He, C.M., 2004, “A
novel fluorescent label based on organic dye-doped silica nanoparticles for
HepG liver cancer cell recognition,” J. Nanosci. Nanotechnol., 4, pp. 585-
589.
167. Santra, S., Liesenfeld, B., Dutta, D., Chatel, D., Batich, C.D., 2005, “Folate
conjugated fluorescent silica nanoparticles for labeling neoplastic cells,”
J. Nanosci. Nanotechnol., 5, pp. 899-904.
